XML 39 R28.htm IDEA: XBRL DOCUMENT v3.25.3
Equity-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity Transactions
The following is a summary of the stock option transactions as of and for the three and nine months ended September 30, 2025:
 Stock Options Outstanding
(amounts in thousands, except shares and per share amount)
Shares Subject to Options Outstanding
Weighted- Average Exercise Price per OptionWeighted- Average Remaining Contractual Terms (in years)Aggregate Intrinsic Value
Balances as of December 31, 20248,762,481$16.97 6.29$2,250 
Options granted—  
Options exercised(24,472)8.47  
Options forfeited / expired(20,516)16.06  
Balances as of March 31, 20258,717,49317.00 6.0414,203 
Options granted—  
Options exercised(99,107)16.30  
Options forfeited / expired(113,097)16.22  
Balances as of June 30, 20258,505,28917.02 5.784,624 
Options granted— 
Options exercised(104,646)9.06  
Options forfeited / expired(116,499)18.00  
Balances as of September 30, 20258,284,144$17.10 5.527,010 
Vested and Exercisable as of September 30, 20257,827,994$17.34 5.50$4,953 
Schedule of Restricted Stock Transactions
The following is a summary of RSU transactions as of and for the three and nine months ended September 30, 2025:
 
Restricted Stock Units
Weighted-Average Grant Date Fair Value
Unvested and outstanding as of December 31, 202413,344,685$9.05 
Granted2,214,28715.48
Vested(1)
(3,004,707)6.74
Forfeited(321,137)8.71
Unvested and outstanding as of March 31, 202512,233,128$10.79 
Granted548,87815.49
Vested(1)
(132,858)8.55
Cancelled/forfeited(561,412)9.56
Unvested and outstanding as of June 30, 202512,087,736$11.08 
Granted128,37715.30
Vested(1,924,932)14.87
Cancelled/forfeited(172,870)9.46
Unvested and outstanding as of September 30, 202510,118,311$10.44 
(1) Includes shares that vested but the issuance and delivery of the shares was deferred.
Schedule of PSUs Transactions
The following is a summary of PSU transactions for the three and nine months ended September 30, 2025:
 Performance-based restricted stock unitsWeighted-Average Grant Date Fair Value
Unvested and outstanding as of December 31, 20248,074,871$5.64 
Granted714,19315.50 
Vested(3,826,723)5.74 
Forfeited(8,334)5.74 
Unvested and outstanding as of March 31, 20254,954,007$6.98 
Granted81,59315.32 
Vested(9,734)5.74 
Cancelled/forfeited(500,634)7.44 
Unvested and outstanding as of June 30, 20254,525,232$7.09 
Granted— 
Vested— 
Cancelled/forfeited— 
Unvested and outstanding as of September 30, 20254,525,232$7.09 
Schedule of Equity-Based Compensation Expense of Operation
Total equity-based compensation expense was presented on the statement of operations as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
(amounts in thousands)2025202420252024
Selling, general and administrative expenses$14,452 $15,769 $44,446 $51,512 
Medical expenses1,775 1,489 4,521 3,384 
Total equity-based compensation expense$16,227 $17,258 $48,967 $54,896